Cargando…

CD47 antibody inhibits tumor recurrence in a clinical relevant glioblastoma animal model

Detalles Bibliográficos
Autores principales:	Zhu, Huaiyang, Yang, Ning, Leiss, Lina, Rygh, Cecilie B, Enger, Per Ø, Bjerkvig, Rolf, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649401/ http://dx.doi.org/10.1186/2051-1426-3-S2-P249

Ejemplares similares

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
por: Zhu, Huaiyang, et al.
Publicado: (2017)

A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma
por: Yang, Ning, et al.
Publicado: (2014)

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma
por: Obad, Nina, et al.
Publicado: (2017)

A novel GFP nude rat model to investigate tumor-stroma interactions
por: Yang, Ning, et al.
Publicado: (2014)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
por: Wang, Jian, et al.
Publicado: (2011)

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
por: Poli, Aurélie, et al.
Publicado: (2013)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells
por: Torsvik, Anja, et al.
Publicado: (2014)

A reproducible brain tumour model established from human glioblastoma biopsies
por: Wang, Jian, et al.
Publicado: (2009)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
por: Fack, Fred, et al.
Publicado: (2014)

Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma
por: Rygh, Cecilie Brekke, et al.
Publicado: (2014)

Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
por: Tanase, Cristiana, et al.
Publicado: (2022)

Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
por: Gholamin, Sharareh, et al.
Publicado: (2019)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016)

Anti-CD47 antibody eliminates bone tumors in rats
por: Fang, Shiqiang, et al.
Publicado: (2019)

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020)

Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
por: Jiang, Nian, et al.
Publicado: (2022)

Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2021)

CD47-blocking therapies stimulate macrophage cytokine secretion and are effective in a model of peritoneal carcinomatosis
por: Weiskopf, Kipp, et al.
Publicado: (2015)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
por: Hutter, Gregor, et al.
Publicado: (2019)

Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma
por: Chen, Jiejian, et al.
Publicado: (2022)

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021)

Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
por: Yang, Yan, et al.
Publicado: (2021)

P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection
por: Schweighardt, B, et al.
Publicado: (2009)

The NADP(+)-dependent IDH1 mutation and its relevance for glioblastoma patient survival
por: Van Noorden, Cornelis JF
Publicado: (2014)

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
por: Todo, Tomoki, et al.
Publicado: (2022)

47. Claudication, Cerebral infarct and Cyclophosphamide
por: Sze, Jeeu Teck
Publicado: (2019)

CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway
por: Liu, Xuejian, et al.
Publicado: (2019)

CD47 on artificial structures
por: Schütz, Christian
Publicado: (2015)

Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies
por: Pietsch, E C, et al.
Publicado: (2017)

Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies
por: Lu, Quansheng, et al.
Publicado: (2020)

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
por: Sun, Jennifer, et al.
Publicado: (2021)

P16-47. Interleukin (IL)-21 induces cytolytic molecule perforin in CD4 and CD8 T cells without CD4 activation in chronically SIV infected rhesus macaques
por: Pahwa, S, et al.
Publicado: (2009)

Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal
por: Li, Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctvgrpb019d4rpkupln23n48dv